… Middleton reports personal fees from Millennium, personal fees from Amgen, personal fees
from Roche, personal fees from Merck, personal fees from Glaxo Smith Kline, personal fees …

Basal cell carcinoma (BCC) is the most common malignant tumour in white populations.
Multidisciplinary experts from the European Dermatology Forum, the European Association of …

Advanced cancer is the second leading cause of death in the western world. Chemotherapy
and radiation are the two main treatment modalities currently available to improve patient …

Talimogene laherparepvec (T-VEC) is a herpes simplex virus type 1-derived oncolytic
immunotherapy designed to selectively replicate within tumors and produce granulocyte …

Background Activating mutations in serine–threonine protein kinase B-RAF (BRAF) are found
in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy improves …

Background Nivolumab and ipilimumab are immune checkpoint inhibitors that have been
approved for the treatment of advanced melanoma. In the United States, ipilimumab has also …

PURPOSE: : To compare, in 305 patients with advanced metastatic melanoma, temozolomide
and dacarbazine (DTIC) in terms of overall survival, progression-free survival (PFS), …

High-intensity focused ultrasound (HIFU) provides a potential noninvasive alternative to
conventional therapies. We report our preliminary experience from clinical trials designed to …

Context Patients with periampullary adenocarcinomas undergo the same resectional
surgery as that of patients with pancreatic ductal adenocarcinoma. Although adjuvant …

High-intensity focused ultrasound (HIFU) has been investigated as a tool for the treatment of
cancer for many decades, but is only now beginning to emerge as a potential alternative to …